[go: up one dir, main page]

AR071880A2 - Metodo para marcar de forma detectable pestivirus - Google Patents

Metodo para marcar de forma detectable pestivirus

Info

Publication number
AR071880A2
AR071880A2 ARP090101842A ARP090101842A AR071880A2 AR 071880 A2 AR071880 A2 AR 071880A2 AR P090101842 A ARP090101842 A AR P090101842A AR P090101842 A ARP090101842 A AR P090101842A AR 071880 A2 AR071880 A2 AR 071880A2
Authority
AR
Argentina
Prior art keywords
pestivirus
marking detectable
detectable
marking
viruses
Prior art date
Application number
ARP090101842A
Other languages
English (en)
Inventor
Gregor Meyers
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of AR071880A2 publication Critical patent/AR071880A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Metodo para atenuar pestivirus, inactivando la actividad de ribonucleasa (actividad de RNasa) que reside en la glicoprote¡na Erns. Se proveen tambien metodos para distinguir entre los virus atenuados de la presente solicitud y virus patogenos.
ARP090101842A 1998-06-05 2009-05-22 Metodo para marcar de forma detectable pestivirus AR071880A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98110356A EP0965639A1 (en) 1998-06-05 1998-06-05 Attenuated pestiviruses

Publications (1)

Publication Number Publication Date
AR071880A2 true AR071880A2 (es) 2010-07-21

Family

ID=8232074

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP990102650A AR020084A1 (es) 1998-06-05 1999-06-04 Pestivirus atenuados
ARP090101843A AR071881A2 (es) 1998-06-05 2009-05-22 Pestivirus atenuados
ARP090101842A AR071880A2 (es) 1998-06-05 2009-05-22 Metodo para marcar de forma detectable pestivirus

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ARP990102650A AR020084A1 (es) 1998-06-05 1999-06-04 Pestivirus atenuados
ARP090101843A AR071881A2 (es) 1998-06-05 2009-05-22 Pestivirus atenuados

Country Status (23)

Country Link
EP (5) EP0965639A1 (es)
JP (3) JP4632540B2 (es)
KR (1) KR100637940B1 (es)
CN (2) CN101085346A (es)
AR (3) AR020084A1 (es)
AT (3) ATE286131T1 (es)
AU (1) AU769823C (es)
BR (2) BRPI9917787B1 (es)
CA (1) CA2330241C (es)
CO (1) CO5050392A1 (es)
CZ (3) CZ301569B6 (es)
DE (3) DE69928700T2 (es)
DK (3) DK1203813T3 (es)
ES (3) ES2235488T3 (es)
HU (3) HU228468B1 (es)
NZ (1) NZ509228A (es)
PE (1) PE20000552A1 (es)
PL (2) PL202509B1 (es)
PT (2) PT1203813E (es)
SI (3) SI1203812T1 (es)
SK (3) SK287014B6 (es)
TR (3) TR200103666T2 (es)
WO (1) WO1999064604A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
EP1104676A1 (en) * 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
PT1149901E (pt) 2000-04-21 2006-08-31 Akzo Nobel Nv Mutantes de pestivirus e vacinas contendo os mesmos
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
UY29915A1 (es) * 2005-11-15 2007-06-29 Boehringer Ingelheim Vetmed Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
CL2008003202A1 (es) 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
UY31930A (es) 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
WO2010051210A1 (en) 2008-10-31 2010-05-06 Boehringer Ingelheim Vetmedica, Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
US8846054B2 (en) 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
CN101915837B (zh) * 2010-07-28 2013-07-03 中国兽医药品监察所 一种猪瘟兔化弱毒活疫苗效力检验方法
ES2606605T3 (es) 2010-09-21 2017-03-24 Intervet International B.V. Vacuna para el BVDV
CN103882051B (zh) * 2014-03-20 2016-04-06 北京市农林科学院 一种检测猪瘟病毒抗体的elisa方法及检测试剂盒
US9993544B2 (en) * 2014-05-23 2018-06-12 Boehringer Ingelheim Vetmedica Gmbh Recombinant classical swine fever virus (CSFV) comprising substitution in the TAV epitope of the E2 protein
KR20220009960A (ko) * 2019-04-18 2022-01-25 베링거 잉겔하임 베트메디카 (차이나) 코포레이션 리미티드 재조합 고전적 돼지 열병 바이러스

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3752389T2 (de) * 1986-01-27 2007-06-14 Schering-Plough Ltd. Attenuierte Herpesviren, Herpesviren die eine Aminosäuresequenz kodierende fremde DNA enthalten, und diese enthaltende Impfstoffe

Also Published As

Publication number Publication date
CN101085346A (zh) 2007-12-12
CO5050392A1 (es) 2001-06-27
DK1084251T3 (da) 2005-04-11
NZ509228A (en) 2003-12-19
WO1999064604A3 (en) 2000-01-27
ATE286131T1 (de) 2005-01-15
SK18232000A3 (sk) 2001-05-10
HU228468B1 (en) 2013-03-28
JP2002517250A (ja) 2002-06-18
EP1203813A2 (en) 2002-05-08
PL202161B1 (pl) 2009-06-30
AU4369299A (en) 1999-12-30
JP2013099357A (ja) 2013-05-23
EP0965639A1 (en) 1999-12-22
BR9911619A (pt) 2001-10-02
EP1614423A2 (en) 2006-01-11
CZ301570B6 (cs) 2010-04-21
CA2330241A1 (en) 1999-12-16
BR9911619B1 (pt) 2013-11-12
BRPI9917787B1 (pt) 2016-09-06
SI1203813T1 (sl) 2006-06-30
AU769823B2 (en) 2004-02-05
DE69929544D1 (de) 2006-04-13
PT1203813E (pt) 2006-06-30
ES2257476T3 (es) 2006-08-01
PT1084251E (pt) 2005-03-31
TR200103664T2 (tr) 2002-06-21
WO1999064604A2 (en) 1999-12-16
JP2010259445A (ja) 2010-11-18
EP1614423A3 (en) 2008-01-30
DE69922953D1 (de) 2005-02-03
AR020084A1 (es) 2002-04-10
KR100637940B1 (ko) 2006-10-23
SK287626B6 (sk) 2011-04-05
ES2235488T3 (es) 2005-07-01
ATE311193T1 (de) 2005-12-15
DE69922953T2 (de) 2005-05-19
AU769823C (en) 2004-11-25
HU228471B1 (en) 2013-03-28
DE69928700D1 (de) 2006-01-05
DK1203813T3 (da) 2006-05-22
CN100374563C (zh) 2008-03-12
EP1084251B1 (en) 2004-12-29
JP5755265B2 (ja) 2015-07-29
SI1203812T1 (sl) 2006-04-30
DE69929544T2 (de) 2006-07-20
AR071881A2 (es) 2010-07-21
CN1304452A (zh) 2001-07-18
TR200103666T2 (tr) 2002-03-21
CA2330241C (en) 2010-09-21
TR200003622T2 (tr) 2001-06-21
ES2253457T3 (es) 2006-06-01
HU228469B1 (en) 2013-03-28
JP5247770B2 (ja) 2013-07-24
PL202509B1 (pl) 2009-06-30
EP1203813A3 (en) 2004-02-04
EP1203812B1 (en) 2005-11-30
EP1084251A2 (en) 2001-03-21
PL348019A1 (en) 2002-05-06
DE69928700T2 (de) 2006-06-22
EP1203812A2 (en) 2002-05-08
SK287625B6 (sk) 2011-04-05
SK287014B6 (sk) 2009-09-07
ATE316380T1 (de) 2006-02-15
SI1084251T1 (en) 2005-08-31
HUP0102707A2 (hu) 2001-11-28
EP1203812A3 (en) 2004-02-04
CZ301569B6 (cs) 2010-04-21
EP1203813B1 (en) 2006-01-25
CZ301494B6 (cs) 2010-03-24
CZ20004533A3 (cs) 2001-07-11
JP4632540B2 (ja) 2011-02-16
HUP0102707A3 (en) 2008-04-28
PE20000552A1 (es) 2000-07-14
DK1203812T3 (da) 2006-04-10
KR20010071406A (ko) 2001-07-28

Similar Documents

Publication Publication Date Title
AR071880A2 (es) Metodo para marcar de forma detectable pestivirus
ATE355380T1 (de) Methode zur selektiven inaktivierung der viralen replication
ES2102081T3 (es) Inductores de parainmunidad multipotentes basados en combinaciones de componentes de poxvirus, metodos para preparar los mismos, y su uso como farmacos.
DK0891420T3 (da) Fremgangsmåde til replikation af influenzavirus i cellekultur samt de ved fremgangsmåden opnåelige influenzavirus
ATE281431T1 (de) Resorcin-derivate
ATE354679T1 (de) Diagnosesysteme auf basis von kulturen gemischter zellen
MX9205443A (es) 4-alcoxi-pirimidinas sustituidas, procedimientos para su preparacion, agentes que las contienen, y su utilizacion como agentes plaguicidas.
BR0110171B1 (pt) filtro de cigarro que compreende fibras de microcavidades, cigarro contendo tal filtro e processo para preparar o filtro de cigarro.
BR9916259A (pt) Composição lìquida aquosa para serviço pesado transparente ou translúcida em uma garrafa lìmpida, e, processo para evitar a degradação de enzima na mesma
MX9303912A (es) Articulo absorbente que tiene aletas alforzadas.
EA200000251A1 (ru) Производные резорцинола
DE69924142D1 (de) Kirschextrakte zur hemmung von cyclooxygenaseenzymen
ES2193604T3 (es) Procedimiento para la coordinacion de componentes de una red.
AR048771A1 (es) Composiciones para efectuar una perdida de peso
UY26335A1 (es) "envases"
BR9711377B1 (pt) processo para adaptação de uma interface aérea de um sistema de rádio privado para que a mesma seja compatìvel com uma interface aérea de uma rede móvel, sistema para uso em possibilitar a um usuário de uma rede de comunicações móveis comunicar-se com um sistema de rádio privado, e sistema de rádio privado.
MX9200762A (es) Derivados de indol, procedimiento para su reparacion y composicion que los contiene.
BR9906070A (pt) Benzamidas substituìdas
BR9814855A (pt) Processo para tratamento antimicrobiano de microrganismos e/ou vìrus, e, composição antimicrobiana.
ES2161412T3 (es) Paquete de vacuna que comprende un recipiente con compuestos vacunales liofilizados.
BR9400361A (pt) Massas que reticulam em elastÔmeros, processo parasua preparaçÃo e emprego
AR047594A1 (es) Articulo para manejo de fluido y metodos para utilizar el mismo
BR9608776A (pt) Processo de uso de ftalocianinas para inativar parasitas do sangue
ES2187504T3 (es) Vectores no oncovirales, basados en el vmmp, con encapsidacion defectuosa.
BRPI0511802A (pt) processo para criação de meios para uso em separadores de ar/óleo

Legal Events

Date Code Title Description
FB Suspension of granting procedure